Discount sale is live
all report title image

Inflation Devices Market Analysis & Forecast: 2025-2032

Inflation Devices Market, By Type (Digital Display and Analog Display), By Capacity (20 ml, 30 ml and 60 ml), By Application (Gastroenterological Procedures, Urological Procedures, Intervention Cardiology & Radiology and Peripheral Vascular Procedures), By End User (Hospitals, Clinics and Ambulatory Surgery Centers), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

  • Published In : 29 Jul, 2025
  • Code : CMI6191
  • Pages :140
  • Formats :
      Excel and PDF
  • Industry : Medical Devices
  • Historical Range: 2020 - 2024
  • Forecast Period: 2025 - 2032

Inflation Devices Market Analysis & Forecast: 2025-2032

Inflation Devices Market is estimated to be valued at USD 5.8 Mn in 2025 and is expected to reach USD 9.9 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.94% from 2025 to 2032.

Key Takeaways

  • According to Type, The Digital Display Category is anticipated to account for the largest share of 64.2% for the Inflation Devices market in 2025, due to its advanced functionality, usability, and integration potential.
  • According to region, North America holds the largest market share of 35.2% for Inflation Devices market growth by 2025, owing to high healthcare spending a big number of powerful industry players.
  • Europe is considered to be the second dominating region with 28.7% market share for Inflation Devices market by 2025. Germany is expected to lead the European inflation device market’s robust, innovation driven expansion, which will be supported by the continents advanced healthcare system which changes demographics and rising desire for minimally invasive procedures.
  • Asia Pacific is considered to be the third largest region with 23.5% market share by 2025 for Inflation Devices market demand, as it is driven by robust market investment, healthcare innovations, and growing demographic.  

Market Overview

The Inflation Devices Market Size is boosted by the the growing elderly population, the rising incidence of gastrointestinal and cardiovascular disorders, and the increased use of minimally invasive surgical techniques. Inflation devices are used to inflate and deflate balloon catheters during angioplasty procedures to treat blocked arteries. The advantages of these devices include precise inflation control and enhanced patient safety.

Current Events and Its Impact on the Inflation Devices Market

Event

Description and Impact

Growing Demand for Minimally Invasive Surgeries

  • Description: In response to the need from surgeons for increased precision in balloon catheter treatments, companies such as Boston Scientific and Merit Medical have developed sophisticated inflation devices with digital pressure monitoring capabilities.  Since 2020, the market for inflation devices with built-in pressure monitoring systems has grown by 25% as a result of these devices' ability to improve patient outcomes and lower procedural complications in cardiology and gastroenterological procedures.
  • Impact: Cardiovascular procedures represent the largest segment of the inflation devices market, accounting for approximately 45% of total market share. The growing prevalence of coronary artery disease, affecting over 18 million Americans annually, has led to increased percutaneous coronary intervention (PCI) procedures, which require specialized inflation devices for balloon catheters and stent deployment.
  • Description: The adoption of minimally invasive surgical techniques in emerging markets has created new growth opportunities for inflation device manufacturers. Countries like India, China, and Brazil have witnessed a 20-30% increase in minimally invasive procedures over the past five years, driven by improving healthcare infrastructure and growing medical tourism.
  • Impact: For example, India's cardiac catheterization procedures have increased by 18% annually, creating a significant demand for cost-effective inflation devices. This geographic expansion has prompted manufacturers to develop region-specific products and establish local distribution networks to capitalize on these emerging opportunities.

Enhanced Market Uncertainty as a Result of International Trade Conflicts

  • Description: The market, valued at approximately $1.2 billion in 2022, has experienced supply chain disruptions and cost pressures due to tariff implementations and trade restrictions. For instance, the 25% tariffs imposed on Chinese medical device components have forced manufacturers like Boston Scientific and Medtronic to reassess their sourcing strategies, leading to increased production costs that are gradually being passed on to healthcare systems.
  • Impact: Supply chain fragmentation has become a critical challenge, with manufacturers diversifying their supplier base to reduce dependency on single-country sourcing. Abbott Laboratories, for example, reported in their 2023 earnings that they invested an additional $150 million in supply chain resilience, including establishing alternative manufacturing facilities in Ireland and Costa Rica for their inflation device components.
  • Description: The semiconductor shortage, exacerbated by trade tensions, has particularly impacted advanced inflation devices with digital pressure monitoring capabilities. Companies like Teleflex reported production delays of 3-4 months for their high-end inflation devices in 2022, directly attributed to chip shortages linked to US-China technology restrictions.
  • Impact: Regional market dynamics have also shifted significantly, with European and Asian manufacturers gaining market share as healthcare providers seek to reduce exposure to US-China trade volatility. German manufacturer B. Braun reported a 15% increase in their inflation device orders from North American hospitals in 2023, while Japanese company Terumo expanded its US manufacturing capacity by 30% to capitalize on the demand for non-Chinese alternatives.

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Pricing Analysis with Cost Percentage

  • Cost remains a critical purchasing factor: both manufacturer and end-user surveys confirm that price sensitivity is high, especially in healthcare institutions managing tighter budgets.
  • Analog devices, which feature manual readings, tend to be more cost-effective, while digital devices equipped with automated systems and software integration command higher prices.
  • Pricing structures indicate that the cost of materials and components can account for 40–50% of the device’s final cost, with regulatory compliance and quality assurance adding another 15–20%.
  • The remainder is split between research and development, marketing, logistics, and margin for manufacturers. As the market matures and competition intensifies, cost efficiency alongside high-value features will play a decisive role in procurement and market share.

Consumer Survey, Feedback, and Unmet Needs

  • Recent surveys and stakeholder feedback in the inflation devices market reveal a heightened focus on precision, efficiency, and innovation. Up to 80% of manufacturers acknowledge the need for devices that provide accurate control and efficient inflation/deflation, suggesting that clinicians continue to demand reliable equipment that streamlines minimally invasive procedures and improves patient safety.
  • Around 75% of stakeholders observe increased adoption among healthcare practitioners, driven by rising cardiovascular cases and an aging population. Digital interfaces and wireless connectivity are emerging as key differentiators, as practitioners desire real-time monitoring and integration with healthcare IT systems.
  • Feedback also underscores unmet needs related to environmental sustainability and regulatory compliance, with 70% of respondents emphasizing the importance of eco-friendly materials and adherence to international standards. Overall, there is clear market pressure for advanced features, connectivity, and sustainable innovation to meet evolving practitioner and institutional priorities.

Analyst Opinion

  • The global inflation devices market is expected to witness steady growth over the forecast period, driven by the increasing demand for minimally invasive surgeries worldwide.
  • The rising prevalence of gastrointestinal diseases and cardiology diseases and the growing geriatric population are fueling the need for efficient inflation devices.
  • Developing healthcare infrastructure in emerging nations and rising medical tourism are creating new avenues for market players.
  • However, the availability of alternative treatment methods for diseases may hamper the demand for inflation devices to some extent.

Segmental Insights

Inflation Devices Market By Type

To learn more about this report, Download Free Sample

Inflation Devices Market Insights, By Type

In terms of type, the digital display segment is expected to contribute largest share of 64.2% for the Inflation Devices market trends in 2025, Out of all the display kinds, the digital display segment of the inflation devices market is expected to grow at the highest rate.  When compared to analog counterparts, digital devices provide this category more precision, ease of use, and advanced display features. 

Digital display inflation devices are becoming more and more popular as healthcare providers and other end users look for more precise and dependable monitoring of inflation and deflation pressures. Historically, analog inflation devices have dominated the market because of their lower cost and portability.

Inflation Devices Market Insights, By Capacity

In terms of capacity, the 60ml segment is expected to contribute the largest share of the Inflation Devices market trends in 2025. One key factor driving this market is its applicability to procedures requiring bigger volumes of inflation fluid, especially in otolaryngology, gastroenterology, and pulmonary applications where larger balloons are frequently utilized and more liquid is needed for inflation.

Additionally, the inflation devices market for angiographic balloons is also witnessing growth, further supporting the demand for higher-capacity devices like the 60ml segment.

Inflation Devices Market Insights, By Application

In terms of application, the interventional cardiology segment is expected to contribute largest share of the Inflation Devices market trends in 2025. Rising prevalence of cardiovascular diseases (CVDs) particularly coronary artery disease due to aging populations and widespread risk factors such as hypertension and diabetes, has led to increased demand for interventional procedures that rely on inflation devices.

Interventional cardiology procedures, such as angioplasty, use inflation devices to inflate and deflate balloons and deploy stents, which are critical steps in restoring blood flow in blocked arteries.

Inflation Devices Market Insights, By End User

In terms of end user, the hospitals segment is expected to contribute largest share of the Inflation Devices market trends in 2025. Due to the continual expansion of the healthcare infrastructure, the rise in healthcare spending, and the ongoing innovation of top manufacturers, the market is anticipated to maintain its dominance and experience significant growth.  Hospitals are more likely to use cutting-edge inflating devices, which will drive market expansion even more.

Regional Insights

Inflation Devices Market Regional Insights

To learn more about this report, Download Free Sample

North America Inflation Devices Market

North America is expected to be the largest market for inflation devices market during the forecast period, accounting for over 35.20% of the market share in 2025. The growth of the market in North America is attributed to the presence of key players and the increasing prevalence of cardiovascular diseases in the region.

Europe Inflation Devices Market

The Europe market is expected to be the second-largest market for inflation devices, accounting for over 28.7% of the market share in 2025. The growth of the market in Europe is attributed to the rising geriatric population and favorable reimbursement policies. An important factor contributing to this growth is the increasing adoption of adjustable pressure by inflation devices, which allows for greater precision and safety during medical procedures.   

Inflation Devices Market In Asia Pacific

The Asia Pacific market is expected to be the fastest-growing market for inflation devices market, with a CAGR of over 23.5% during the forecast period. The growth of the market in Asia Pacific is attributed to improving healthcare infrastructure and increasing healthcare expenditure in the region.    

Inflation Devices Market Dominating Countries

U.S Inflation Devices Market

The presence of significant medical device makers and a high rate of cardiovascular disorders, which fuel demand for minimally invasive treatments where inflation devices are crucial, further support the nation's leadership.  Strong growth in the U.S. market is anticipated due to ongoing investments in healthcare infrastructure, rising procedure volume, and the gradual use of automated and digital inflation device technology.   

India Inflation Devices Market

The growing burden of chronic diseases, particularly cardiovascular conditions, and a rapidly increasing geriatric population are catalyzing the adoption of minimally invasive procedures that use inflation devices. India's market growth is strongly supported by government and private sector initiatives aimed at upgrading hospital capabilities, expanding access to advanced procedures, and increasing awareness around early disease diagnosis.    

Inflation Devices Market In China

The country is witnessing strong demand for advanced medical devices as rising urbanization, escalating incidence of chronic illnesses, and favorable government policies direct more resources to healthcare. Significant investment in hospital infrastructure, increased focus on minimally invasive surgery, and rising healthcare spending — both public and private — are accelerating market expansion.

Market Report Scope

Inflation Devices Market Report Coverage

Report Coverage Details
Base Year: 2024 Market Size in 2025: USD 5.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.94% 2032 Value Projection: USD 9.9 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Digital Display and Analog Display
  • By Capacity:  20 ml, 30 ml and 60 ml
  • By Application: Gastroenterological Procedures, Urological Procedures, Intervention Cardiology & Radiology and Peripheral Vascular Procedures
  • By End User: Hospitals, Clinics and Ambulatory Surgery Centers
Companies covered:

Medtronic, Boston Scientific Corporation, Abbott, Teleflex Incorporated, Convatec Inc., Smiths Group plc, Cook, B. Braun SE, Cardinal Health and Stryker

Growth Drivers:
  • Increasing prevalence of cardiovascular diseases 
  • Favorable reimbursement scenario
  • Rising minimally invasive surgeries 
  • Increasing healthcare expenditure
Restraints & Challenges:
  • High cost of advanced inflation devices
  • Lack of trained professionals 
  • Stringent regulatory policies

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Inflation Devices Market: Growth Drivers

  • Increasing prevalence of cardiovascular diseases: The rising prevalence of cardiovascular diseases such as coronary artery disease and heart failure is driving the demand for angioplasty procedures, which is subsequently fueling the growth of the inflation devices market. According to the World Health Organization (WHO), in June 2021, cardiovascular disease is the number one cause of death globally, responsible for over 17 million deaths per year.
  • Favorable reimbursement scenario: The availability of reimbursement for angioplasty procedures is increasing the adoption of inflation devices. Public and private insurance providers are increasingly covering expenses related to cardiovascular treatments due to the risks associated with heart diseases.
  • Rising minimally invasive surgeries: The shift from traditional open surgeries toward minimally invasive procedures is boosting the adoption of inflation devices used in balloon-based surgeries such as angioplasty. Minimally invasive surgeries reduce hospital stays and costs.
  • Increasing healthcare expenditure: The growing healthcare spending by governments and individuals globally is leading to higher adoption of advanced cardiovascular devices and treatments, thereby driving the inflation devices market. According to Centers for Medicare & Medicaid Services, healthcare spending in the U.S. is estimated to reach US$6.2 trillion by 2028.

Inflation Devices Market: Trends

  • Shift toward digital inflation technologies: Manufacturers are increasingly developing digital inflation devices integrated with electronic pressure sensors, LCD displays, and intuitive user controls. Digital interfaces allow improved visibility, accuracy, and control over inflation.
  • Focus on patient safety and comfort: Key market trends include the incorporation of safety mechanisms such as pressure relief valves, ergonomic lightweight handles, and mechanisms to reduce balloon deflation time. Companies are designing patient-friendly CE Certified Inflation Devices to ensure compliance with regulatory standards while enhancing user safety and performance.
  • Development of intuitive handheld devices: Trending product innovations include compact, lightweight handheld inflation devices with advanced digital interfaces, making them easier to handle and transport. Intuitive display and control panels improve usability.

Inflation Devices Market: Opportunities

  • Growth prospects in emerging economies: The rising prevalence of cardiovascular diseases, along with improving healthcare infrastructure in developing nations such as India, China, Brazil, etc., is expected to create significant opportunities for inflation device manufacturers. A favorable regulatory scenario is also attracting key players to emerging markets.
  • Development of smart inflation devices: Integration of technologies such as IoT, artificial intelligence, and machine learning into inflation devices can help improve patient monitoring and enable data-driven, precise inflation control. Companies are working on developing connected, smart inflation devices.
  • Increasing adoption of disposable devices: The growing trend of using disposable devices to reduce cross-contamination risks presents lucrative opportunities for market players. Disposable inflation devices eliminate maintenance and sterilization costs.
  • Expansion of application areas: The widening clinical applications of inflation devices in procedures such as balloon sinuplasty, airway dilation, balloon gastrointestinal procedures, etc. is creating new avenues for market growth. 

Inflation Devices Market: Key Developments

  • In June 6, 2023, SYNDEO Medical, a division of MDev BV, a global leader in the design and development of fully integrated custom procedural solution products, is pleased to introduce the SATURN Inflation Device. This innovative platform offers interventional physicians worldwide a new level of innovation, versatility, and choice. By seamlessly integrating into SYNDEOPack intervention packages, the SATURN Inflation Device provides healthcare professionals with a comprehensive solution that combines the benefits of both products on a single platform.
  • In November 2022, Merit Medical Systems, Inc. announced the commercial launch of the basixALPHA Inflation Device in the U.S. The basixALPHA is the latest addition to the Merit portfolio of inflation devices. Products include low- and high-pressure capacity analog and digital devices for inflating, deflating, and measuring pressures in angioplasty balloons.

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Digital Display
    • Analog Display
  • Capacity Insights (Revenue, USD Bn, 2020 - 2032)
    • 20 ml
    • 30 ml
    • 60 ml
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Gastroenterological Procedures
    • Urological Procedures
    • Intervention Cardiology & Radiology
    • Peripheral Vascular Procedure
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital
    • Clinics
    • Ambulatory Surgery Centers
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa
  • Key Players Insights
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • Teleflex Incorporated
    • Convatec Inc.
    • Smits Group plc
    • Cook
    • Braun SE
    • Cardinal Health
    • Stryker

Sources

Primary Research Interviews

  • Regulatory Affairs Specialists
  • Hospital Purchasing Committees
  • Interventional Cardiologists
  • Supply Chain Heads – Medical Distributors

Databases

  • FDA MAUDE Database
  • CMS (Centers for Medicare & Medicaid Services) Database

Magazines

  • Medgadget
  • MedCity News
  • HealthTech Magazine
  • MPO (Medical Product Outsourcing)

Journals

  • Biomedical Engineering Online
  • Journal of Biomedical Materials Research
  • European Heart Journal
  • Annals of Biomedical Engineering
  • The Lancet Digital Health

Newspapers

  • Business Standard – Medical Devices
  • Mint – Pharma & Medtech
  • The Hindu BusinessLine – Healthcare
  • Times of India – Health

Associations

  • Association for the Advancement of Medical Instrumentation (AAMI)
  • Asia Pacific Society of Interventional Cardiology (APSIC)
  • Advanced Medical Technology Association (AdvaMed)
  • Indian Medical Device Industry Association (IMEDICA)
  • Interventional Cardiovascular Technology Association (ICTA)

Proprietary Elements

  • CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 8 years

*Definition: The inflation devices market refers to the global market for medical devices used to inflate and deflate balloon catheters during various minimally invasive surgical procedures and examinations. Inflation devices allow controlled and safe inflation and deflation of angioplasty and other balloons during cardiovascular interventions as well as balloons used for gastrointestinal, urological, gynecological, and ear-nose-throat procedures. They are an indispensable part of balloon dilatation procedures. The most common types of inflation devices include syringes, pumps, bags, and automated inflation systems. Key end-users are hospitals, ambulatory surgery centers, and diagnostic imaging centers.

Share

Share

About Author

Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.

Missing comfort of reading report in your local language? Find your preferred language :

Frequently Asked Questions

The Inflation Devices Market sise is estimated to be valued at USD 5.8 Mn in 2025, and is expected to reach USD 9.9 Mn by 2032.

The CAGR of the global Market is projected to be 7.94% from 2025 to 2032.

The major factors driving the market growth are rising prevalence of cardiovascular diseases and GI disorders, increasing adoption of minimally invasive surgeries, technological advancements in inflation devices, growing elderly population, and favorable reimbursement policies.

The digital display segment accounts for the largest share in the market owing to benefits like automatic pressure sensing and control.

The major players operating in the market are Medtronic, Boston Scientific Corporation, Abbott, Teleflex Incorporated, Convatec Inc., Smiths Group plc, Cook, B. Braun SE, Cardinal Health and Stryker.

North America is expected to dominate the market during the forecast period owing to high adoption of minimally invasive procedures and new product launches.

Select a License Type

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.